The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a mult
The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a multiplexed qualitative test intended for the simultaneous detection and identification of multiple viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of respiratory tract infection.
OZE,OEM,OCC,OEP,OZZ,OOU
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (Hmpv) Rna Assay System,Respiratory Virus Panel Nucleic Acid Assay System,Influenza A Virus Subtype Differentiation Nucleic Acid Assay,Bordetella Pertussis Dna Assay System,Parainfluenza Multiplex Nucleic Acid Assay
2
Respiratory Pathogens Flex (RP Flex) Nucleic Acid Test Cartridge
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, quali
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a mult
The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a multiplexed qualitative test intended for the simultaneous detection and identification of multiple viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of respiratory tract infection.
OZE,OEM,OCC,OEP,OZZ,OOU
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (Hmpv) Rna Assay System,Respiratory Virus Panel Nucleic Acid Assay System,Influenza A Virus Subtype Differentiation Nucleic Acid Assay,Bordetella Pertussis Dna Assay System,Parainfluenza Multiplex Nucleic Acid Assay
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene® System is a qualitative nucleic acid multiplex test intended to simultaneously detect and identify multiple respiratory virus nucleic acids in nasopharyngeal (NP) swab specimens from individuals with signs and symptoms of respiratory tract infection.
The Verigene® Processor SP is an instrument which integrates sample preparation,
The Verigene® Processor SP is an instrument which integrates sample preparation, target amplification, and target hybridization within a single device as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
OOI,NSU
Real Time Nucleic Acid Amplification System,Instrumentation For Clinical Multipl
Real Time Nucleic Acid Amplification System,Instrumentation For Clinical Multiplex Test Systems
The Verigene® Reader is the central control of the Verigene® System, a benchtop
The Verigene® Reader is the central control of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications. (Refurbished)
NSU,OOI
Instrumentation For Clinical Multiplex Test Systems,Real Time Nucleic Acid Ampli
Instrumentation For Clinical Multiplex Test Systems,Real Time Nucleic Acid Amplification System
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative m
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed using the sample-to-result Verigene® System, is a qualitative multiplexed in vitro diagnostic test for the simultaneous detection and identification of selected gram-negative bacteria and resistance markers.
PEN
Gram-Negative Bacteria And Associated Resistance Markers
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
NQX,PAM
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococc
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen,Gram-Positive Bacteria And Their Resistance Markers
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene® System is a qualitative nucleic acid multiplex test intended to simultaneously detect and identify multiple respiratory virus nucleic acids in nasopharyngeal (NP) swab specimens from individuals with signs and symptoms of respiratory tract infection.
OCC
Respiratory Virus Panel Nucleic Acid Assay System
2
Respiratory Virus Plus (RV+) Nucleic Acid Test Cartridge
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed us
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed using the sample-to-result Verigene® System, is a qualitative multiplexed in vitro diagnostic test for the simultaneous detection and identification of selected gram-negative bacteria and resistance markers.
PEN
Gram-Negative Bacteria And Associated Resistance Markers
2
Gram-Negative Blood Culture (BC-GN) Nucleic Acid Test Cartridge
The Verigene® Processor SP is an instrument which integrates sample preparation,
The Verigene® Processor SP is an instrument which integrates sample preparation, target amplification, and target hybridization within a single device as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications. (Refurbished)
NSU,OOI
Instrumentation For Clinical Multiplex Test Systems,Real Time Nucleic Acid Ampli
Instrumentation For Clinical Multiplex Test Systems,Real Time Nucleic Acid Amplification System
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene®
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
NPQ,OMM,NPR
Test, Factor V Leiden Mutations, Genomic Dna Pcr,Test 5, 10-Methylenetetrahydrof
Test, Factor V Leiden Mutations, Genomic Dna Pcr,Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr,Test, Factor Ii G20210a Mutations, Genomic Dna Pcr
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative m
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene®
The Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+) on the Verigene® System is a qualitative nucleic acid multiplex test intended to simultaneously detect and identify multiple respiratory virus nucleic acids in nasopharyngeal (NP) swab specimens from individuals with signs and symptoms of respiratory tract infection.
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, quali
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed us
The Verigene® Gram-Negative Blood Culture Nucleic Acid Test (BC-GN) performed using the sample-to-result Verigene® System, is a qualitative multiplexed in vitro diagnostic test for the simultaneous detection and identification of selected gram-negative bacteria and resistance markers.
PEN
Gram-Negative Bacteria And Associated Resistance Markers
The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a mult
The Verigene® Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) is a multiplexed qualitative test intended for the simultaneous detection and identification of multiple viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of respiratory tract infection.
OZE,OEM,OCC,OEP,OZZ,OOU
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (
Influenza A And Influenza B Multiplex Nucleic Acid Assay,Human Metapneumovirus (Hmpv) Rna Assay System,Respiratory Virus Panel Nucleic Acid Assay System,Influenza A Virus Subtype Differentiation Nucleic Acid Assay,Bordetella Pertussis Dna Assay System,Parainfluenza Multiplex Nucleic Acid Assay
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
NQX,PAM
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococc
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen,Gram-Positive Bacteria And Their Resistance Markers
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene®
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
NPQ,OMM,NPR
Test, Factor V Leiden Mutations, Genomic Dna Pcr,Test 5, 10-Methylenetetrahydrof
Test, Factor V Leiden Mutations, Genomic Dna Pcr,Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr,Test, Factor Ii G20210a Mutations, Genomic Dna Pcr
2
Hypercoagulation Panel (HC) Nucleic Acid Test Cartridge
The Verigene® Reader is the central control of the Verigene® System, a benchtop
The Verigene® Reader is the central control of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
OOI,NSU
Real Time Nucleic Acid Amplification System,Instrumentation For Clinical Multipl
Real Time Nucleic Acid Amplification System,Instrumentation For Clinical Multiplex Test Systems
The Verigene® Processor is an instrument which internalizes all of the functions
The Verigene® Processor is an instrument which internalizes all of the functions required to process a Test Cartridge as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
NSU
Instrumentation For Clinical Multiplex Test Systems
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative m
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative mul
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
OZN
C.Difficile Toxin Gene Amplification Assay
2
Clostridium difficile (CDF) Nucleic Acid Test Cartridge
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, quali
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualita
The Verigene® Enteric Pathogens Nucleic Acid Test (EP) is a multiplexed, qualitative test for simultaneous detection and identification of common pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.
MRSA/SA ELITe MGB™ is a qualitative in vitro diagnostic test for the direct dete
MRSA/SA ELITe MGB™ is a qualitative in vitro diagnostic test for the direct detection of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) DNA purified from nasal swabs. MRSA/SA ELITe MGB™ is intended to aid in the prevention and control of MRSA infections in healthcare settings. It is not intended to diagnose MRSA infections or to guide or monitor treatment for MRSA infections. A negative result does not preclude MRSA/SA nasal colonization. Concomitant cultures are necessary to recover organisms for epidemiological typing or for further susceptibility testing.
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
Gram-Positive Blood Culture (BC-GP) Nucleic Acid Test Cartridge
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
Gram-Positive Blood Culture (BC-GP) Nucleic Acid Test Cartridge
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
Gram-Positive Blood Culture (BC-GP) Nucleic Acid Test Cartridge
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed us
The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).
Gram-Positive Blood Culture (BC-GP) Nucleic Acid Test Cartridge
The ARIES® MRSA Assay is an integrated real-time polymerase chain reaction (PCR)
The ARIES® MRSA Assay is an integrated real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection of methicillin–resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in patients at risk for nasal colonization
The iCubate, Inc. iC-GPC Assay for use on the iC-System is a qualitative, multip
The iCubate, Inc. iC-GPC Assay for use on the iC-System is a qualitative, multiplexed, in vitro diagnostic test for the detection and identification of potentially pathogenic gram positive bacteria, which may cause bloodstream infection (BSI). The iC-GPC Assay is performed directly on positive blood cultures, confirmed by Gram stain to contain gram positive cocci.